Management of opioids and persistent pain (MOPP) study

Not Applicable

• Conditions: Persistent non-cancer pain; Signs and Symptoms

• Registration Number: ISRCTN45616481
• Lead Sponsor: Keele University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-05-13
• Last Update Posted: 16 October 2023
• Study Completion: 2025-03-31

Recruitment & Eligibility

• Status: Ongoing
• Sex: All
• Target Recruitment: 896

Inclusion Criteria

1. Adult patients aged =18 years
2. Prescribed any opioid analgesic (defined as any opioid or opioid/paracetamol combination analgesic from sections 4.7.2 and 4.7.1 British National Formulary [BNF]) for chronic non-cancer pain continuously for =6 months
3. Prescription issued within the previous 2 months

Exclusion Criteria

1. Patients being treated for acute pain (self-limiting pain, for example after injury or surgery), pain associated with cancer and patients with terminal illness (life expectancy <6 months)
2. Vulnerable patients (e.g. severe mental illness, learning difficulties, dementia)
3. Patients currently receiving treatment for substance misuse

Study & Design

• Study Type: Interventional
• Study Design: Not specified